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Objective: To review the therapist effects literature since Baldwin and Imel's (2013) review. 
Method: Systematic literature review of three databases (PsycINFO, PubMed and Web of Science) 
replicating Baldwin and Imel (2013) search terms. Weighted averages of therapist effects (TEs) were 
calculated, and a critical narrative review of included studies conducted. 
Results: Twenty studies met inclusion criteria (3 RCTs; 17 practice-based) with 19 studies using 
multilevel modeling. TEs were found in 19 studies. The TE range for all studies was 0.2% to 29% 
(weighted average = 5%). For RCTs, 1%–29% (weighted average = 8.2%). For practice-based studies, 
0.2–21% (weighted average = 5%). The university counseling subsample yielded a lower TE (2.4%) 
than in other groupings (i.e., primary care, mixed clinical settings, and specialist/focused settings). 
Therapist sample sizes remained lower than recommended, and few studies appeared to be 
designed specifically as TE studies as opposed to maximising on the availability of large routine 
patient datasets.  
Conclusions: Therapist effects are a robust phenomenon although considerable heterogeneity exists 
across studies. Patient severity appeared related to TE size. TEs from RCTs were highly variable. 
Using an overall therapist effects statistic may lack precision, and TEs might be better reported 
separately for specific clinical settings.  
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Introduction  
Psychotherapy research has traditionally focussed on either the treatment modality or the patient 
when investigating the effectiveness of psychological therapies (Wampold & Imel 2015). However, 
most psychotherapy outcome studies employ multiple therapists that treat a range of patients, and 
this hierarchical structure of patients nested within therapists creates the opportunity to study the 
relative impact of therapists on outcomes (Wampold 2001). A number of studies have recognised 
the nested structure in the analysis and have shown that therapists do play a significant role in 
patient outcomes – a phenomenon termed as a therapist effect (e.g., Baldwin & Imel 2013; 
Barkham, Lutz, Lambert, & Saxon 2017; Lutz & Barkham 2015).  
A therapist effect measures the similarity between the outcomes of patients treated by the same 
therapist and is akin to the intraclass correlation coefficient (ICC; Raudenbush & Bryk 2002). The ICC 
can also be interpreted as the proportion of the total outcome variance attributable to the variability 
between therapists, with larger ICCs reflecting greater variability. For example, an ICC of 0.05 – that 
is, a therapist effect of 5% – means that 5% of the variance in patients' outcomes is accounted for by 
the variability between therapists.  
Therapist effects have been reported regardless of context or methodology, or whether the study 
has high internal validity as in the case of a clinical trial (e.g., Kim, Wampold, & Bolt 2006) or high 
external validity as in the case of practice-based (i.e., naturalistic) studies (e.g., Saxon & Barkham 
2012). Evidence regarding therapist effects is important because it: (1) redresses the over-attention 
paid to comparing ‘brands’ of therapy (e.g., Barkham et al. 2017); (2) can identify the more and less 
effective therapists, which enables potentially better matching of patients to therapists (e.g., 
Boswell, Kraus, Constantino, Bugatti, & Castonguay 2017); (3) has the potential for advancing 
theory-practice links by identifying the characteristics and practices of more and less effective 
therapists (e.g., Wampold, Baldwin, Grosse Holtforth, & Imel 2017); and (4) can generate research 
questions for potential intervention studies aimed at reducing variability between therapists in an 
effort to improve overall service performance (e.g., Saxon, Firth, & Barkham 2017).  
This review focusses on studies of therapist effects and seeks to review and critique the therapist 
effects evidence base published since the field was previously reviewed and summarized by Baldwin 
and Imel (2013) in their chapter in the 6th Edition of Bergin and Garfield's Handbook of 
Psychotherapy and Behavior Change. It is noteworthy that their chapter replaced previous chapters 
in earlier editions focusing on therapist variables (e.g., Beutler et al. 2004), thereby reflecting the 
increased research attention on this phenomenon.  
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Therapist effects: A brief history  
Therapist effects appear to have first been commented on by Ricks (1974). When comparing two 
therapists who treated emotionally disturbed adolescents, four out of 15 (27%) treated by one 
therapist in comparison to 11/13 (85%) treated by the other therapist went on to develop adult 
schizophrenia. The adolescents called the former therapist ‘supershrink’ due to recognizing aspects 
of the therapist's actions that they felt were beneficial (Ricks 1974). These actions have been 
summarized in terms of the therapist providing greater “effort, greater support of clients' autonomy, 
use of resources outside of therapy, and better relationships with clients' parents” (Najavits & 
Strupp 1994; p.115). The other therapist became depressed and had very little energy for the most 
disturbed cases (Ricks 1974). Crucially, variability between the actions of the two therapists seemed 
to emerge in response to the more severely disturbed adolescents.  
However, the issue of variability between therapists continued to be largely ignored in 
psychotherapy research. A review of 33 studies by Martindale (1978) found that the majority (21; 
63%) did not recognize practitioner variability and just one study (3%) treated practitioners as if 
drawn randomly from the population of practitioners, which would have made the results 
generalizable. In light of these findings, Martindale stated that researchers were inappropriately 
generalizing findings beyond the practitioners involved in outcome studies.  
A meta-analysis by Crits-Christoph et al. (1991) marked the first summary quantitative statement of 
the research evidence regarding therapist effects. This study reported that across 27 different 
treatment groups, therapists accounted for an average of 8.6% of the outcome variance. Wampold 
(2001) similarly found that therapist effects accounted for approximately 8% of the outcome 
variance, while the effects of specific treatments hovered around zero. Okiishi, Lambert, Nielsen, 
and Ogles (2003) highlighted the extent of variability in outcomes achieved by different therapists 
sampled from a single clinic and their results were consistent with findings from multisite studies. 
Brown, Lambert, Jones, and Minami (2005) reported that clients seen by the most effective 
therapists from a variety of treatment settings achieved three times as much change as compared 
with those showing least change.  
In 2013, Baldwin and Imel provided the most detailed summary to date of the therapist effects 
literature. They identified 25 studies reporting fixed effects analyses (i.e., where comparisons are 
restricted to the sample of therapists used in each individual study) and 46 studies using random 
effects (where results can be generalised to the population of therapists). For the fixed effects 
studies, no summary breakdown was provided for RCT and practice-based studies regarding the 
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percentage split or median/mean number of therapist and patients per study. Of the 46 random 
effects studies, 29 were efficacy studies (i.e., trials) yielding a therapist effect of approximately 3% 
and 17 were naturalistic or effectiveness studies yielding a therapist effect of 7%. This difference 
may be explained by therapist effects being suppressed in trials due to tight inclusion criteria, 
adherence checks, manualization, close supervision and smaller samples of therapists. The overall 
average therapist effect found across the studies was 5% and the most effective therapists were 
twice as effective on average when compared with the least effective therapists. These random 
effects studies yielded a total of 1218 therapists and 14,519 patients, but the median number of 
therapists per study was only 9 (range 2 to 581), and in only two studies did the mean number of 
patients per therapist exceed 30 (Cella, Stahl, Reme, & Chalder 2011; Dinger, Strack, Leichsenring, 
Wilmers, & Schauenburg 2008).  
The evidence base for therapist effects, therefore, increasingly supports the view that some 
therapists facilitate better patient outcomes than others. Hence, despite policy guidance (e.g., 
National Institute for Care and Clinical Excellence [NICE] guidelines e.g., NICE 2009) implying 
homogeneity of delivery (i.e., for problem x, apply therapy y), the therapist effects phenomenon 
suggests that, at the point of delivery, significant heterogeneity exists between therapists. Therapist 
effects also appear to prevail regardless of whether the context is a clinical trial (e.g., Huppert et al. 
2001) or a study of routine clinical practice (e.g., Saxon & Barkham 2012), although the size of effect 
varies.  
Variability in size of therapist effect  
In the study by Crits-Christoph et al. (1991) the therapist effect ranged from 0% to 48% across 15 
studies, while in Baldwin and Imel's (2013) review therapist effects ranged from 0% to 55% across 46 
random effect studies. The heterogeneity of the studies included in these reviews is cited as the 
cause of the variability of effects, although currently little is known about the specific effects of 
different factors on the size of therapist effect (Baldwin & Imel 2013; Wampold 2007).  
There are four main factors that may contribute to the size of therapist effect: the statistical 
approach adopted, sample size, the case mix variables included in the analyses, and the clinical 
setting. First, different statistical approaches adopted in studying therapist effects can lead to 
different results (e.g., Elkin, Falconnier, Martinavich, & Mahoney 2006; Kim et al. 2006). The 
statistical approach recommended to investigate therapist effects is multilevel modeling (MLM), 
sometimes termed hierarchical linear modeling (HLM), in which the hierarchical structure in the data 
is recognised (Adelson & Owen 2012). This allows for the separation of the outcome variance 
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between the therapist level (level 2) and the patient level (level 1) and the calculation of the 
proportion that is at the therapist level, which is the therapist effect (Raudenbush & Bryk 2002; 
Wampold & Brown 2005). MLM avoids potential Type I and Type II errors arising from single level 
approaches (Hox 2010), such as the use of analysis of variance (e.g., Huppert et al. 2001), although 
this latter study was subsequently reanalyzed using MLM (see Huppert et al. 2014). And, particularly 
important, MLM also controls for patient variables and case mix. The Baldwin and Imel (2013) 
review found that not all studies used multilevel or random effects analysis.  
Secondly, large sample sizes, particularly of therapists, are required to estimate statistically reliable 
therapist (i.e., level 2) effects (see Maas & Hox 2005; Schiefele et al. 2017). Low power resulting 
from small numbers of patients in traditional outcome studies (Kazdin & Bass 1989) will also lead to 
under-powered therapist effect studies (Crits-Christoph, Tu, & Gallop 2003; Owen, Drinane, Idigo, & 
Valentine 2015). The smaller the sample size at each level of the multilevel model, the greater the 
risk of over or under estimating the size of therapist effects (Baldwin & Imel 2013). A key 
recommendation for future therapist effect studies made in the Baldwin and Imel (2013) review was 
for researchers to acquire larger sample sizes to avoid power issues and sampling error. Another 
recommendation called for more studies that were designed from the outset as a therapist effect 
study.  
The third factor is the list of case-mix variables that are included in any analyses. For example, 
Okiishi et al. (2006) found that controlling for patient initial severity explained a considerable 
amount of the variability between therapists, while random slopes for patient severity, where the 
relationship between patient severity and outcome varies between therapists, has been a consistent 
finding of therapist effect studies (Schiefele et al. 2017). The relationship between number of 
sessions attended and outcome has also been found to vary between therapists. Saxon et al. (2017) 
found a therapist effect of 2% where patients received 2 treatment sessions and 40% where they 
received 20 sessions or more. The case-mix variables controlled for will have an influence on the size 
of therapist effect.  
The final factor, linked to the third, is the clinical setting from which the data was collected. 
Therapist effects are based on the average patient in the sample and the mean values of case-mix 
variables included in the analysis. It might, therefore, be anticipated that therapist effects may differ 
across different types of clinical settings that reflect different patient populations. In the same way 
that therapist effects have been found to differ as a function of patient severity within a single 
setting (Saxon & Barkham 2012), the same phenomenon might be present across clinical settings 
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that serve patients presenting with differing clusters of psychological issues and from differing social 
contexts.  
Review questions  
In light of the above considerations, the current narrative and empirical review updates and refines 
the review carried out by Baldwin and Imel (2013). In particular, it provides a practical and pragmatic 
framework for considering therapist effects according to clinical settings, which may reflect differing 
levels of patient severity and different presenting conditions by the patients. This framework is 
consistent with the original observation of the differential impact of patient severity by Ricks (1974) 
and observations reported by Barkham et al. (2017) that patient severity may be a key determinant 
in the extent to which therapist effects are present. Accordingly, the primary aim of the review is to 
report the individual and combined size of ICCs reported in publications or in advance on-line from 
clinical trials and practice-based studies in the time period 2012 to 2016 inclusive. And, in light of 
Baldwin and Imel's (2013) call for larger studies and studies designed specifically to investigate 
therapist effects, we report on the extent to which these two recommendations have been met.  
Method 
Identification of studies  
A systematic literature search was conducted using title and abstract searches of three online 
databases (PsycINFO, PubMed and Web of Science) and dates within the 5-year range January 2012 
to December 2016. This included early on-line publications appearing during this time period that 
were subsequently published in hard copy in 2017. The start date was chosen to ensure continuity 
from Baldwin and Imel's (2013) review and search terms were replicated: “Therapist effects” or 
“therapist outcome” or “differential effects of therapists” or (therapist and “intraclass correlation”) 
or (therapist and (multilevel or “hierarchical linear modelling” or “mixed models”)) or “effective 
therapist” or “ineffective therapist” or “therapist variance”. Reference lists of retrieved studies were 
also examined to identify further studies that may have been missed due to limiting the search 
terms as above. Preferred reporting items for systematic reviews (PRISMA) procedures were 
adopted (see Figure. 1; Moher, Liberati, Tetzlaff, & Altman 2009). After initial identification of 
studies (n = 2132), duplicates were removed, and 1566 studies examined against the inclusion 
criteria. Full texts of the resulting 47 studies were retrieved and examined, leading to further 
exclusion of 26 studies, resulting in 21 studies. One of these was a meta-analysis which was also 
excluded, yielding 20 studies included in the review.  
Study selection criteria 
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Studies were included if they met the following inclusion criteria: a) published in a peer-reviewed 
journal, b) investigated therapist effects in a clinical population, c) published in hard copy or early 
on-line January 2012–December 2016, d) study samples were adults, e) written in English, and f) an 
empirical study examining quantitative treatment outcomes in which the focus on therapist effects 
was a central aim of the study. This latter criterion was premised on the recommendation that 
therapist effect studies should be designed primarily as studies of therapist effects rather than 
having therapist effects as a secondary interest (Baldwin & Imel 2013). Exclusion criteria were in 
keeping with therapist effects recommendations (Wampold 2005) and were the reverse of the 
inclusion criteria or having a primary focus on process variables (e.g., alliance, adherence) or patient 
dropout rates.  
Quality assessment 
All studies were quality assessed using a modified Downs and Black (1998) checklist. Modifications 
were informed by statistical (Adelson & Owen 2012), power (Schiefele et al. 2017) and reporting 
recommendations (Baldwin & Imel 2013) for therapist effect studies. Specifically, the power 
question was adapted to reflect therapist effects sampling recommendations for both therapists and 
patients. The sample size of therapists is generally considered most important for the reliability of 
therapist effects (e.g. Adelson & Owen 2012). Maas and Hox (2005) recommended at least 100 
therapists for unbiased estimates of effects but a sample of 50 therapists would yield acceptable 
effects. Schiefele et al. (2017) recommended a sample of 1200 patients which could be derived from 
different combinations of therapists and patients. The required number of patients per therapists is 
likely to be determined by the number of therapists and also the focus of the study. As such, there is 
no single agreed value for the number of therapists or patients. 5 = ≥100 therapists all treating ≥10 
patients each; 4 = ≥100 therapists with some or all treating <10 patients or 50–99 therapists all 
treating ≥10 patients each; 3 = 50–99 therapists with some or all therapists treating <10 patients; 2 = 
10–49 therapists all treating ≥10 patients; 1 = 10–49 therapists with some or all therapists treating 
<10 patients; and 0 = <10 therapists. See Appendix A for the full checklist with details of adaptations.  
The first author (RGJ) rated all articles. Two independent raters (final year trainee clinical 
psychologists) familiar with the original Downs and Black (1998) checklist from use of it in their own 
research, determined reliability of the quality checklist scores. Each rater examined a different set of 
20% of all studies (i.e., 4 studies) to maximise the breadth of sampling of ratings. Each set of studies 
comprised one RCT study and three naturalistic outcome studies, including one from each of the 
highest and lowest quartile and two from the middle 50% of overall quality scores as determined by 
the first author. The Downs and Black (1998) sample mean (SD) scores of 14 (6.39) for RCT studies 
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and 11.7 (4.64) for naturalistic outcome studies were used as the quality benchmarks. See Appendix 
B for details of rater agreement levels.  
Data extraction  
As noted above, the therapist effect is derived from the intraclass correlation coefficient (ICC) 
defined as:  
 
where σt⁠ 
2⁠ represents the variance at the therapist level and σe⁠ 
2⁠ represents the variance at the 
patient level. The ICC, therefore, gives the proportion of the total outcome variance that is 
associated with the therapist, which is multiplied by 100 to give the therapist effect as a percentage. 
For each study in the review, the ICC was reported or calculated where sufficient information was 
provided. To calculate an overall weighted average ICC, three parameters were considered; number 
of patients, number of therapists, and number of patients per therapist (Schiefele et al. 2017). Mean 
ICCs weighted by patient were calculated by summing the individual products of each ICC and 
number of patients, then dividing by the total number of patients. Similar calculations were 
conducted to obtain mean ICCs weighted by therapist and mean ICCs weighted by number of 
patients per therapist.  
Results 
Organisation and details of included studies  
The final 20 selected studies meeting the inclusion criteria comprised either randomised control 
trials (n = 3; 15%) or naturalistic outcome studies (n = 17; 85%). Within the naturalistic studies, we 
grouped the studies according to four broad clinical settings as follows. (1) University counseling 
centers comprised studies defined as being based in and serving university or college students. (2) 
Primary care settings comprised locally run services that are deemed to be the first port of call for 
patients experiencing psychological difficulties. They might normally take referrals directly from 
General Practitioners or Family Physicians. This group also included services in the UK that were set 
up under the UK government's Improving Access to Psychological Therapies (IAPT) services (see 
Clark, 2011). The IAPT service adopts a stepped-care model in which patients are first seen by a 
Psychological Well-being Practitioner (PWP) who delivers a low intensity intervention (e.g., 
psychoeducational, self-help). If no improvement is made, patients are stepped-up to receive a high-
intensity intervention (e.g., cognitive-behavioral therapy) delivered by a traditional therapist. (3) 
Mixed clinical settings comprised studies that sampled patients from across differing types of 
services and were therefore, by definition, more heterogeneous. And (4) Specialist/focused settings, 
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which were identified as comprising more severe and enduring patients with very defined clinical 
presentations and interventions.  
Table 1 summarises the included studies and presents information on the number of patients, 
therapists, mean number of patients per therapist, SD, and lowest and highest number of patients 
per therapist. Individual studies are noted in terms of these descriptives as follows: patients >1200 
(denoted by *); therapists >100 (denoted by ††); lesser threshold >50 (denoted by †); minimum 
patients per therapist >10 (denoted by ‡).  
In addition, Table 1 provides information on patient diagnosis, outcome measures, treatment 
setting, statistical analysis, results, and quality rating. Studies are grouped by type of study (RCT or 
naturalistic practice-based studies), with the naturalistic studies grouped according to the four broad 
clinical settings. Studies within each group are listed alphabetically. Studies were qualitatively 
reviewed according to the above categories.  
The mean number of patients per study was 6157 (range 91–48,648; SD=10,695) and the median 
was 3929.5 (IQR = 599–6277.5). The mean number of therapists was 187 (range 3–1800; SD = 402.2) 
and the median was 57.5 (IQR = 33.25–161), yielding a mean number of patients per therapist of 47 
(range 6–135). The most common presenting diagnosis was depression/anxiety (n = 7; 33%) and the 
most common outcome measure used was the Patient Health Questionnaire-9 (PHQ-9; n = 6; 29%). 
The majority of studies investigated a range of different therapies within the same study and were 
therefore termed ‘mixed psychotherapy’ (n = 11; 52%). Nineteen studies (95%) used a hierarchical 
design, and 19 studies (95%) found a significant therapist effect.  
RCT studies 
Details of the RCT studies providing eligible data (n = 3) are presented in Table 1. The mean (SD) 
number of patients, therapists and patients per therapist were as follows: patients (M = 362.3; SD = 
309.9); therapists (M = 17; SD = 18.5); and patients per therapist (M = 42; SD = 49.6). The only study 
meeting any of the power criteria was Goldsmith, Dunn, Bentall, Lewis, and Wearden (2015) in 
relation to all therapists having >10 patients each.  
Naturalistic studies  
Overall, for the 17 studies, the mean (SD) number of patients, therapists and patients per therapist 
were as follows: patients (M = 7561.7; SD =11,294.2); therapists (M = 218.6; SD = 430.4); and 
patients per therapist (M = 52.6; SD = 40.7). For the four groupings of service context, the equivalent 
values were as follows: university counseling centers (n = 5), patients (M = 6027.2; SD = 4928.5), 
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therapists (M = 240.2; SD=208.1), and patients per therapist (M=24; SD=14.1); for primary care 
settings (n = 6), patients (M = 4734.8; SD = 3560.8), therapists (M = 55.3; SD = 34.4), and patients per 
therapist (M = 81.8; SD = 36.7); for mixed clinical settings (n = 4), patients (M = 15,803; SD = 
21,929.6); therapists (M = 531; SD = 848.3); and patients per therapist (M = 190; SD = 18.5); and for 
specialist/focused settings (n = 2), patients (M = 147.5; SD = 62.9); therapists (M = 17.5; SD = 10.6); 
and patients per therapist (M = 9.0; SD = 1.4).  
In terms of the product of patient and therapists, we considered a conservative calculation of 
Schiefele's criterion of 1200 patients by using the lowest reported number of patients per therapist 
rather than the mean. As shown in Table 1 (denoted by *), nine studies met this criterion with all of 
them, except Hayes, McAleavey, Castonguay, and Locke (2016) and Schiefele et al. (2017), having a 
minimum of at least 10 patients per therapist. In terms of the number of patients, therapists, and 
lowest number of patients per therapist, four studies met all three criteria including number of 
therapists >100: Goldberg, Hoyt, Nissen-Lie, Nielsen, & Wampold 2016; Goldberg et al. 2016; Nissen-
Lie et al. 2016; and Saxon and Barkham (2012). Four further studies met the three criteria when 
number of therapists >50: Chow et al. (2015); Firth, Barkham, Kellett, and Saxon (2015), Kraus et al. 
(2016); and Saxon et al. (2017).  
Quality ratings  
All studies exceeded the quality benchmark scores (range 20–27) and were therefore included in the 
review. Agreement between the two independent raters and the original rater were: rater 1, κ = 
0.72, and rater 2, κ = 0.66 (both p<0.01). See Appendix B for the full results of the quality checklist. 
There was no significant correlation between year of publication and quality score for either all 
studies (N = 20; r = 0.35, p=.13) or practice-based studies (N = 17; r = 0.21, p = .43). For the RCTs, the 
mean (SD) quality rating was 22.3 (2.08), 95% CI = 20.0 to 24.7). For naturalistic studies, the mean 
(SD) quality rating was 24.4 (2.1), 95% CI = 23.3 to 25.4. For each of the four groups, the summary 
statistics were as follows: university counseling centers, M = 24 (3.1), 95% CI = 21.3 to 26.7; primary 
care settings, M = 25.3 (1.5), 95% CI = 24.1 to 26.5; mixed settings, M = 24.5 (1.3), 95% CI = 23.2 to 
25.8; and specialist/focused settings, M = 22 (other values = 0). In sum, with the exception of the 
two specialist/focused studies, the mean quality of naturalistic studies exceeded those of RCT 
studies, with the quality ratings for primary care studies obtaining the highest mean quality ratings.  
Study methods and components  
Table 2 presents a summary of the methods and components used in each study design. The three 
trials showed a range of follow-up measure time-points, practitioner groups and analytical methods. 
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In the naturalistic designs, 11/17 (65%) collected pre-post data as opposed to sessional and no study 
collected follow-up data. The focus of the main outcome measures was mixed, split between 
symptom measures and those measures tapping a range of presenting issues. The most frequently 
controlled variable was severity, in 10/17 (59%) studies. In terms of therapists, most studies 
described their samples differently, suggesting a wide variation in the professional backgrounds and 
affiliations of therapists. Only 5/17 (29%) of studies included additional variables in their 
investigations of therapist effects. All but three of the naturalistic studies used 2-level analysis for 
calculating the ICCs.  
Average therapist effect size  
Tables 3 and 4 show details of the ICCs reported (or calculated if the ICC was not reported) for each 
model and outcome measure and the mean ICCs for each study. Converted to therapist effects (i.e., 
percentages), effects from individual models varied from 0.2% to 29%. The average effect across all 
studies, weighted by number of patients was 4.9% and by number of therapists was 5.0%. When 
weighted for number of patients per therapist, the effect was 5.4%. This implies that across studies, 
approximately 5% of the variance in outcomes was attributable to the therapist.  
The average effect for the 3 RCT studies was 12.9% weighted by number of patients, 17.4% weighted 
by number of therapists and 8.2% weighted by number of patients per therapist, giving a therapist 
effect between 8.2% and 17.4%. For naturalistic studies, the mean effect was 4.7% weighted by 
number of patients, 4.8% weighted by number of therapists and 5.0% weighted by number of 
patients per therapist, giving an overall therapist effect of around 5%.  
The average effects for each of the four groups was also calculated. For university counseling 
centers: 3.1% (weighted by patient; range 0.1–15.3%), 3.6% (weighted by therapist; range 0.5–
16.2%) and 2.7% (weighted by patient per therapist; range 0.4–7.3%). For primary care: 5.1% 
(weighted by patient; range 0.1–22.0%), 4.3% (weighted by therapist; range 0.2–19.0%) and 4.8% 
(weighted by patient per therapist; range 0.2–13.8%). For mixed clinical services: 5.9% (weighted by 
patient; range 0.2–60.4%), 6.1% (weighted by therapist; range 0.4–57.9%) and 5.9% (weighted by 
patient per therapist; range 1.1–26.1%). And for specialist/focused services: 13.0% (weighted by 
patient; range 11.7–13.8%), 12.5% (weighted by therapist; range 10.5–14.6%) and 15.0% (weighted 
by patient per therapist; range 8.9–25.3%).  
Therapist effect and sample sizes  
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To determine the association between therapist effect and the N of patients, therapists, and 
patients per therapist in each study, we calculated Spearman's rho for various groupings on the 
studies. For all studies (n = 20), correlations were significant for the N of patients (−0.63, p<.003) and 
for N of therapists (−0.67, p<.001). That is, the larger the N values, the lower (more conservative) the 
therapist effect. The N for patients per therapist was not significant (p>.05). For naturalistic studies 
(n = 17), only the N of therapists was significant (−0.64, p < .005). Neither the N of patients nor N of 
patients per therapist was significant (p values = .054 and 0.69 respectively). When only the 14 
naturalistic studies using MLM were considered, both the N of therapists and N of patients were 
significant (−0.71, p<.004, and−0.61, p<.02 respectively).  
Reporting bias  
In order to assess the presence of reporting bias, a funnel plot of ICC scores against number of 
patients per therapist was constructed (see Figure 2). Each dot on the plot represents one of the 
ICCs in Tables 2 and 3 and patients per therapist was chosen as the most representative measure of 
sample size. Although asymmetrical due to not being able to have an ICC below zero, the graph 
indicates possible over reporting of large effects where the samples are small.  
Review of randomised control trials  
In this section, we focus on reviewing the RCTs identified in the search and on issues impacting on 
the heterogeneity within settings (i.e., design and aims, outcomes, variables) and possible reasons 
for different effects. Three studies investigated therapist effects within RCTs (Erickson, Tonigan, & 
Winhusen 2012; Goldsmith et al. 2015; Moyers, Houck, Rice, Longabaugh, & Miller 2016) and 
therapist effects ranged from 1 to 29%.  
In Goldsmith et al.’s (2015) study, outcome was level of fatigue and physical functioning, and 
patients were randomised both to one of the three nurses and one of two treatment arms 
(pragmatic rehabilitation or supportive listening) with the nurses delivering both interventions. The 
analyses employed regression models rather than MLM and found no therapist effects in either 
treatment arm. Whilst it could be argued that randomisation nullified any therapist effect, the use of 
only three nurses made it the smallest sample in this review and the only study employing nurses. 
Additionally, unlike all other studies included in the review, outcome measures were more related to 
physical symptoms. Hence, the study appears substantially different on key design factors that make 
it unrepresentative of other studies in the area.  
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Erickson et al. (2012) also used randomisation to therapist when investigating therapist effects in 
pregnant substance users. Taken from a larger RCT, participants were all randomised to either 
manualised motivational enhancement therapy (MET) or treatment as usual (TAU). Outcomes were 
self-reported substance use and urine analysis and MLM found a therapist effect of 29% for the MET 
condition, which disappeared when one of the 10 therapists was excluded. Limitations of the study 
included low therapist numbers and the issue that some patients were receiving other treatments 
concurrently.  
Moyers et al. (2016) investigated therapist effects and therapist empathy in an RCT of behavioral 
treatment during an alcohol reduction program. Results showed that 11% of outcome variance (i.e., 
alcoholic drinks per week) was associated with therapists. Empathy levels were not found to vary 
between therapists, but within-therapist variations were apparent across therapy sessions (e.g., 
during sessions of higher empathy, larger decreases in drinking behaviours occurred). A major 
limitation of the study was that empathy was rated by observers rather than by patients.  
Review of naturalistic practice-based studies  
In this section, we focus on reviewing the 17 practice-based studies identified in the search and 
focus on issues impacting on the heterogeneity within settings (i.e., design and aims, outcomes, 
variables) and possible reasons for different effects. We considered these studies in the four 
groupings identified earlier.  
University counseling centers.  
Six studies analysed data from US university counseling centres (Goldberg, Hoyt, et al. 2016; 
Goldberg, Rousmaniere, et al. 2016; Hayes et al. 2016; Hayes, Owen, & Bieschke 2015; Nissen-Lie et 
al. 2016; Owen, Adelson, Budge, Kopta, & Reese 2016). Therapist effects ranged from 0.4–19.1% 
with a weighted average of 2.4%. This smaller than average effect may reflect the fact that the 
sample comprised patients (i.e., students) who presented with less severe symptoms.  
Owen et al. (2016) calculated therapist effects from three subscales of the BHM-20. Results showed 
therapist effects of <1% for wellbeing, 4.6% for symptom distress and 7.5% for life functioning. 
Although the overall therapist effect of 2.4% was relatively small compared to effects in other 
settings, these findings are consistent with the evidence that the more complex the presenting 
problems, (i.e., symptom distress and life functioning compared to wellbeing), the greater the 
variability between therapists. One limitation of the study was validity of the subscales with the 
wellbeing subscale comprising only three items and the life functioning subscale comprising four 
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items. Accordingly, these scales may miss both broader and more specific aspects of patient change 
(and thus therapist variability).  
Therapist effects over time.  
Two studies within this group investigated the extent to which the effectiveness of therapists varied 
over time (Goldberg, Hoyt, et al. 2016; Goldberg, Rousmaniere, et al. 2016). Therapist effects ranged 
from 0.09–1.1%. In Goldberg, Hoyt, et al.’s (2016) study, the highest and lowest 10% of therapists 
were classified into high performing or low performing groups. Results showed a small overall 
therapist effect of 0.089%, alongside an increasing discrepancy between high and low performing 
groups as treatment duration increased This implies that the therapist becomes more important as a 
function of the duration of therapy, which may be a proxy for the severity and complexity of the 
presenting problems.  
Goldberg, Rousmaniere, et al. (2016) investigated whether effect sizes increased as therapist 
experience increased. MLM showed a therapist effect of 1% with effect sizes of therapists 
decreasing very slightly over time, with wide variation in different therapists' trajectories. 
Limitations included the heterogeneity of the therapists in terms of experience and treatment 
approach and the lack of recording of training and supervision received. Although both Goldberg 
studies calculated an overall therapist effect, they did not consider whether this overall therapist 
effect within the sample varied at different time points.  
Racial diversity.  
A further two studies investigated therapist effects in populations comprising a diversity of White 
and racial/ethnic minority (REM) clients. Hayes et al. (2015), using MLM analysis, found that the 
variability in therapists' outcomes was a partial function of the REM status of the patients. Two 
limitations of the study were the small number of therapists and patients and the single treatment 
centre. Hayes et al. (2016) extended the previous study across 45 university counseling services, 
finding a therapist effect of 3.9%. Overall, both REM and non-REM patients experienced similar 
levels of symptom reduction. However, the study identified some therapists as having better 
outcomes with REM patients than non-REM patients, while this was reversed for other therapists.  
Primary care settings (including Improving Access to Psychological Therapies studies).  
Six studies investigated therapist effects in UK primary care settings: IAPT high intensity (n=1; Saxon 
et al. 2017), IAPT low intensity (n=3; Ali et al. 2014; Firth et al. 2015; Green, Barkham, Kellett, & 
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Saxon 2014), and mixed (n = 1; pre-IAPT, Saxon & Barkham 2012; n = 1; IAPT, Pereira, Barkham, 
Kellett, & Saxon 2017). Therapist effects in these studies ranged from 0.9–9.7%.  
Low intensity  
Ali et al. (2014) investigated the effects of treatment characteristics by examining therapist effects in 
brief low-intensity psychological interventions provided by Psychological Wellbeing Practitioners 
(PWPs). Routinely collected outcome measures for depression and anxiety were analysed in an IAPT 
service. They used a three-level hierarchical structure with sessions at level 1, patients at level 2, and 
PWPs at level 3. Results showed therapist effects of 1% for the depression measure (PHQ-9) and 
0.9% for anxiety (GAD-7). All PWPs had outcomes that were not statistically different from the 
‘average’ PWP in the sample. These relatively low therapist effects may be attributable to the low 
initial severity of patients (i.e., mild-to-moderate depression/anxiety) and/or case complexity of the 
sample. However, the authors used a three-level hierarchical model with sessions at the lowest level 
and did not control for initial severity, which may have constrained the overall therapist effect and 
result in a more likely explanation of the low therapist effect. The lowest reported number of 
patients per therapist was one. Firth et al. (2015) investigated therapist effects and efficiency in 
PWPs in a similar IAPT service to Ali et al. (2014) and using outcome measures for anxiety, 
depression and functional impairment. A therapist effect of 6–7% was moderated by initial symptom 
severity, duration of treatment and non-completion of treatment. The most effective PWPs were 
found to achieve nearly twice the change per session in comparison to less effective peers. The 
study found a much larger therapist effects than Ali et al. (2014) in a very similar service with 
identical outcome measures but used a 2-level model.  
Green et al. (2014) also investigated PWPs across 6 IAPT clinics and found therapist effects of 9–11% 
controlling for pre-treatment severity. The study by Green et al. (2014) also highlighted that 
therapist resilience, organisation, knowledge and confidence were associated with more effective 
therapists.  
High intensity  
Saxon et al. (2017) investigated therapist effects in a large naturalistic dataset of patients receiving 
counseling or CBT in an IAPT service. After controlling for case mix, a therapist effect of 5.8% was 
found. Completion of therapy and higher number of sessions attended were both associated with 
larger therapist effects and more effective therapists were found to have recovery rates twice that 
of the less effective therapists. There was no significant difference in the effect size between CBT 
and counseling.  
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Low and high-intensity  
Saxon and Barkham (2012) used MLM to investigate therapist effects in patients receiving 
psychological therapy or counseling in a primary health care setting across an 8-year period 
(immediately before the establishment of the IAPT initiative but comprising patients who would 
have been very similar to those later referred to the IAPT service). Results showed a therapist effect 
of 6.6%. Greater initial patient severity and higher therapist caseload risk levels were associated with 
poorer outcomes, with the effect ranging from 1% to 10% as severity varied and the effect being 
reduced from 7.8% by the inclusion of therapist caseload risk. However, the least effective therapists 
had almost half the recovery rate of the above average therapists.  
Pereira et al. (2017) analysed data from a single IAPT service, measuring patient depression 
outcomes and therapist self-reports of resilience and mindfulness. An overall therapist effect of 
6.7% was found across high and low-intensity IAPT therapists, with more effective therapists having 
higher levels of mindfulness, along with resilience and mindfulness combined.  
Mixed clinical settings.  
Four studies compared therapist effects in mixed clinical settings – that is, studies pooling patients 
from a variety of settings: Chow et al. (2015), Kraus et al. (2016;), Nissen-Lie et al. (2016), and 
Schiefele et al. 2017). Therapist effects ranged from 1.3% to 12.9%.  
Chow et al.’s (2015) main sample, derived from 45 organizations, yielded a 5.1% therapist effect 
using a 3-level model. They investigated a subsample of 17 therapists with 1632 patients. For this 
subsample, not reported in Table 1, the mean therapist caseload was 94.24 (SD = 97.40; Mdn = 
46.00; minimum = 10, maximum = 335).They found that the characteristic that best predicted 
effectiveness was the amount of time dedicated by therapists to improving their therapeutic skills, 
termed deliberate practice, supporting the view that more dynamic qualities of therapists may be 
related to therapist effects.  
Kraus et al. (2016) investigated therapist effects across a range of sub-domains of the Therapy 
Outcomes Package (TOP; Kraus, Seligman, & Jordan 2005) and across a wide range of treatment 
settings. Scores were risk-adjusted by intake score, risk score, and then with a full random forest 
model. The TOP yields 12 subscales and therapist effects across these outcome domains when fully 
risk-adjusted ranged from 1.6–18.7%, with an overall effect of 12.9%. We considered only the overall 
effect because of concerns in generating 12 TEs from a single study. Similar to Owen et al. (2016), 
the quality of life measure produced a higher therapist effect, along with suicidality, substance 
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abuse and depression. Mania produced the lowest therapist effect, which may reflect its relation to 
general health. A limitation of the study was that not using random slopes in the analysis may have 
missed those therapists who were better at treating patients of a specific level of severity (e.g., mild 
or severe).  
Nissen-Lie et al. (2016) investigated whether outcome measures and therapist effects were 
consistent across two different treatment contexts. Data from a US university counseling center and 
a secondary care unit in Sweden were analysed using the Outcome Questionnaire-45 (OQ-45; 
Lambert et al. 2004) and the Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM; 
Evans et al. 2002) respectively. MLM showed that therapists effective in one domain of an outcome 
measure tended also to be effective in other domains, a finding that held across both treatment 
centres. However, in the US sample there were no therapist effects found for the OQ-45, whereas in 
the Swedish sample therapist effects for the CORE-OM ranged from 5.7% to 10%. It is likely that the 
differences in the severity of patients between the two centers will have contributed to the 
difference in effects. However, the authors also attributed the assignment of patients to therapist, 
based on CORE-OM scores, at the Swedish center, as a possible cause. The extent and methods of 
patient allocation is often unreported or unclear in studies, yet it may have some effect on therapist 
outcome variability.  
Schiefele et al. (2017) combined data from eight naturalistic datasets and used standardized 
outcomes and MLM, controlling for intake severity, to find an overall therapist effect of 6.7%. 
Individual therapist effects across the datasets ranged from 2.7–10.2%, with a weighted average of 
5.7%. The authors identified the heterogeneity of the studies as a reason for the range of effects. 
The study also provided sample size recommendations for the number of therapists and number of 
patients per therapist required for practice-oriented studies.  
Specialist/focused settings.  
Two studies presented with substantially different characteristics from those reported in the 
preceding three groups. These two studies (Laska, Smith, Wislocki, Minami, & Wampold 2013; 
Wiborg, Knoop, Wensing, & Bleijenberg 2012) focused on highly specific patient presenting 
problems that targeted psychological/physical issues and using outcome measures not adopted in 
any other studies. Laska et al. (2013) drew on an archival dataset of veterans and utilised supervisor 
ratings of therapist characteristics, similarly to Green et al. (2014). A therapist effect of 12% was 
found. Supervisors identified characteristics of more effective therapists including the ability to 
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address, in particular, client avoidance, adopt a flexible interpersonal style and the ability to build 
strong therapeutic alliances.  
Wiborg et al. (2012) investigated therapist effects in manualised CBT for chronic fatigue syndrome at 
three community-based mental health care centres. A therapist effect of 21% was found in terms of 
post-treatment fatigue. This therapist effect decreased when therapists had a more negative 
attitude towards use of evidence-based treatment manuals. It was also found that the setting in 
which therapy was delivered had an effect on outcomes, with negative attitudes towards 
manualization being more clustered within certain treatment centers.  
Discussion 
This review has provided a systematic examination and evaluation of the status of therapist effects 
research for the period 2012 to 2016 inclusive, as well as determining, as recommended by Baldwin 
and Imel, whether study size has increased and whether studies have been specifically designed to 
address therapist effects. We found studies reported therapist effects in 19 of the 20 studies 
meeting the inclusion criteria, confirming previous evidence that differences in the effectiveness of 
therapists occurs across a wide range of clinical settings, patient groups, and also across datasets 
drawn from routine practice or trials (Baldwin & Imel 2013; Crits-Christoph et al. 1991). Indicative of 
this variability in setting and design is the range in the size of therapist effects found, namely 0.2–
29.0%. However, this range was narrower than the 0–48.7% range reported by Crits-Christoph et al. 
(1991). The current finding of a weighted average therapist effect of 5% across 31 models lies within 
the average range of 3–7% reported by Baldwin and Imel (2013).  
Although a 5% effect is small relative to the effect of patient variability, studies from the review 
reported some therapists being consistently more than twice as effective as others after controlling 
for case-mix (e.g., Firth et al. 2015; Saxon & Barkham 2012). This review confirms that therapists 
make an important contribution to the variability in patient outcomes (Baldwin & Imel 2013). More 
specifically, patient intake severity is emerging as a consistent predictor of therapist effect size, with 
larger effects occurring with more severe patients. This effect was observed in the four clinical 
groupings of studies (i.e., with university counseling centers at the lower end and specialist/focused 
settings at the upper end), but this remains an observation in terms of clinical settings in the 
absence of a greater number of studies within each of the groups. There would, however, be a logic 
in therapist effects being potentially more critical in clinical settings where the patient population is 
more severe as a parallel to the finding that the more severe the patient, the more it matters which 
therapist a patient sees (Schiefele et al. 2017).  
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However, an overall therapist effect of 5% masks the differences in the size of the effect found in 
each study. These differences arise from a combination of design and context factors that have the 
potential to decrease or increase the size of the effect. The analytic method and the sample size are 
key factors to the size and reliability of therapist effects. The most consistent analytic methods and 
largest samples were found in naturalistic studies and the therapist effects were also more 
consistent, indicating the importance of methods and an appropriate sample size in reported effects. 
However, some of these groupings contain few studies and there is heterogeneity between the 
studies in the same group. Therefore, this interpretation is tentative.  
The finding of larger therapist effects in RCTs compared to naturalistic studies is contrary to the 
results reported by Baldwin and Imel (2013) and is somewhat counterintuitive. It would be expected 
that the use of a treatment protocol and the endeavor to ensure that only the treatments differed 
would yield smaller therapist effects. The current finding may reflect the heterogeneity of RCT 
studies and limited sample sizes. In the current review, only three trials were quantitatively 
analysed, and each study had much smaller sample sizes of therapists than recommended by Maas 
and Hox (2005). In general, the concept of therapist effects in the contexts of an RCT, where 
variability is suppressed, needs to be carefully considered as compared with practice-based studies 
where variability is a natural component. However, the fact that therapist effects have been found in 
RCTs provides further evidence as to the prevalence of the phenomenon. But future trials need to be 
designed using more therapists to achieve the required number of patients in order to better 
understand therapist effects in each treatment arm of a trial.  
Naturalistic studies, with their larger sample sizes, particularly of therapists, appear better suited to 
the study of therapist effects because they allow for suitably powered MLM analyses. Indeed, in only 
the two specialist/focused studies (Laska et al. 2013; Wiborg et al., 2012) and one of the naturalistic 
studies (Hayes et al. 2015) did the number of patients not meet the criterion of 1200, the product of 
the number of therapists and the mean number of patients per therapist, as recommended by 
Schiefele et al. (2017). However, the mean number of patients per therapist only provides an 
average and does not indicate the lowest number of patients allocated to a therapist, which 
provides confidence in the value of the patients per therapist calculation. Using the lowest number 
of patients assigned to a therapist as representing the most conservative number of patients per 
therapist in any single study and using this as the multiplier with the number of therapists, nine of 
the 17 naturalistic studies met the criterion of 1200 patients as proposed by Schiefele and colleagues 
(including the Schiefele et al., study). Hence, fractionally in excess of half the practice-based studies 
could confidently be said to have met the guideline criterion proposed by Schiefele et al. (2017).  
Therapist effects since Baldwin & Imel’s (2013) review   21 
Regarding Baldwin and Imel's (2013) call to increase sample sizes of studies, the number of patients, 
in particular, increased in the sample of current studies. But recall that in Baldwin and Imel's (2013) 
review, the median number of therapists per study was only 9 and in only two (4%) of 46 studies did 
the number of patients per therapist exceed 30. In the current sample comprising RCTs and practice-
based studies, the median number of therapists per study was 57.5 and in 12 (60%) of the studies 
the number of patients per therapist exceeded 30 Hence, it would appear that the recommendation 
has been heeded and sample sizes have increased, although this applies more to practice-based 
studies rather than RCTs.  
However, an issue remains as to the extent to which studies, even practice-based studies, are 
designed as therapist effect studies. Studies of routinely collected data remain limited to the 
variables already collected, and few contain much more than the basic therapist variables. The 
primary hallmark of studies is the large N of patients. Information that may provide insight into 
therapist effects is rarely available. However, a small number of studies have applied different 
methods to move the study of therapist effects forward, by linking routinely collected data to 
therapist questionnaires of specific variables that might impact on the effect (e.g. Green et al. 2014). 
A recommendation we would make is that this area of work requires specific studies of therapist 
effects that collect multiple measures on a sufficient number of therapists (e.g., minimum of 50) as 
well as meeting the target of a minimum of 1200 patients overall (Schiefele et al. 2017). And, 
consistent with this approach, that reports should include the same level of information on 
therapists as for patients. The reporting should also display the actual distribution of individual 
patients to therapists.  
A theme across the studies in the current review was that the more complex the outcome measure 
(i.e., broader based sampling symptoms, functioning, relationships), the higher the therapist 
variability – again reflecting findings of the influence of severity on therapist effect (Saxon & 
Barkham 2012). However, a recommendation from the current study is that reliable and well 
validated outcome measures are used, and that the reliability of measures is reported, particularly 
where the outcome used is a subscale (e.g. Owen et al. 2016). Some of the studies in the current 
review (e.g., Kraus et al. 2016; Nissen-Lie et al. 2016) explicitly used subscales in pursuit of more 
specific effects. However, many of the subscales of such instruments used (e.g., CORE-OM, TOP) lack 
evidence of discriminant validity between subscales. In future, we recommend that studies report 
evidence of the discriminant validity if multiple outcomes are used, otherwise each subscale is not 
yielding reliable additional information.  
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Despite the identification of some patterns of therapist effect size, the overriding observation from 
this review was the degree of heterogeneity of studies, particularly in terms of important factors in 
determining therapist variability, such as study populations and outcomes and sample sizes at 
different levels. This concern regarding heterogeneity dissuaded us from carrying out a meta-
analysis. Indeed, we suggest that the state of current research argues against carrying out a 
meaningful meta-analysis. It may be more profitable to determine why there are differences 
between therapist effects reported across studies rather than to attempt to determine a single point 
estimate for therapist effects.  
This review, by identifying some of the potential causes of heterogeneity aims to inform future study 
designs. It is also worth noting that a smaller therapist effect is not an indicator of generally better 
outcomes, only that there is less variability around the average therapist outcomes. For patients, a 
smaller therapist effect indicates a more restricted range of possible patient outcomes, but it does 
not state what the absolute value of an outcome might be. The aim is to improve the outcome 
represented by the ‘average’ therapist and the study of variability and therapist effects is a means to 
achieve this aim.  
Study limitations  
There are a number of caveats to the present review, many of which are due to the limitations of the 
included studies and their reported descriptions and results. Where it was reported, studies varied 
in the extent to which patients were randomised or allocated to therapists, and the effect of method 
of patient allocation on the size of therapist effects is currently unclear (e.g. Goldsmith et al. 2015; 
Moyers et al. 2016; Nissen-Lie et al. 2016).  
There is a tendency to assume the reliability, validity and meaning of both the therapist and patient 
measures used in therapist effect studies. Different care systems will also dictate differing methods, 
timings and intensity of data collection and studies tend not to report the timing of measurements 
and how this is integrated into psychological care. For example, taking an outcome measure 
following a session is different to taking the same measure before it.  
For the current review, the same search terms as Baldwin and Imel (2013) were used, which may not 
have identified all recent studies. For example, a specific term searching for counseling was not 
used. Also, stringent inclusion and exclusion criteria limited studies to those that specifically focused 
on therapist effects, and predominantly on outcome measures. Importantly, we excluded 11 studies 
that were judged to focus on process variables (e.g., alliance). Applying the 5-point scale post hoc to 
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determine power within each study (i.e., N of therapists and patients), we found all studies to be 
rated 2 with the exception of Imel et al. (2014), which was rated 4 due to employing 189 therapists 
but the patient sample included standardized patients with a mean of less than 3 sessions per 
therapist. In sum, none of these studies met the criterion of 1200 patients (Schiefele et al., 2017). 
Inclusion of any of these studies may have impacted on the results. For example, Huppert et al. 
(2014) found small effects in the context of a trial, which would likely have reduced the therapist 
effect reported for trial data given the small number of studies reported.  
After completing the review and at a stage too late for inclusion in the tables, we found a study by 
Berglar et al. (2016) that was relevant, within the search time frame, and only listed in Web of 
Science but which, inexplicably, did not get identified by the search terms and, therefore, did not 
appear in the original pool of 1566 references. The study comprised 237 patients and 68 therapists, 
but only one-third saw five or more patients each and no therapist saw 10 patients or more. Hence, 
it was rated as 3 for power and did not meet the criterion of 1200 patients. Their results supported 
the phenomenon of a therapist effect and, most interestingly, found that the therapists’ impact on 
treatment outcome not only increased the higher the severity of patients’ psychological problems, 
but that more effective therapists worked even more effectively with patients with higher levels of 
psychological severity.  
The calculation of overall therapist effects, whilst being indicative of general trend, combines data 
from a range of different contexts and is limited to the particular effects that particular studies 
reported. For example, some studies accounted for initial severity or case mix in their calculations 
and others did not. It is also worth noting that whilst large routine datasets can provide sufficiently 
powered studies, such datasets are predetermined and often driven by pragmatic audit and 
evaluation concerns rather than theory or research, and it is virtually impossible to include 
additional measures to extant data collection systems.  
Recommendations and implications for practice and policy  
This review has shown that the therapist effect reported by Baldwin and Imel (2013) is a durable and 
robust phenomenon that creates many potential implications for the delivery of services and the 
training and supervision of therapists. Differential effectiveness is unlikely to be due to the action of 
a single factor and is far more likely a multicomponent phenomenon. One hypothesis is that it 
relates to individual therapists carrying out a number of selected elements very well and that these 
elements differ or overlap between therapists.  
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However, certain actions for training and practice arise. In terms of training, findings may challenge 
the ever-increasing focus on academic achievements in the selection of therapists for training and 
might suggest an emphasis on processes containing active components; for example, role play 
(Armstrong 2001). Similarly, therapist characteristics such as resilience might also play a role in 
selection (Green et al. 2014; Pereira et al. 2017).  
Once trained, the allocation of patients to therapists should take account of patient severity and 
more severe patients need to be matched to more effective therapists. Some of the methods 
developed in therapist effect papers are able to identify the more effective therapists (e.g. Saxon & 
Barkham 2012). These methods could also enhance clinical supervision by providing more reliable 
feedback regarding the relative effectiveness of a therapist compared to their peers and include 
wider indices of patient outcome such as dropout, completion and clinical change rates (e.g. Green 
et al. 2014; Saxon et al. 2017). Highly effective therapists could be given a clinical supervision role in 
services and make recordings of sessions regularly available to colleagues and peers. Service 
managers need to try to encourage an organisational climate that recognises therapist effects 
without critical judgment (Hunter, Bedell, & Mumford 2007). In this climate, staff can be engaged 
and curious as to any identified differences and seek methods to close the gap in terms of patient 
outcomes between therapists via group supervision.  
Finally, in terms of policy, psychological treatment guidelines (e.g., the UK National Institute for 
Health and Care Excellence guidelines) could include statements to the effect that variability exists 
as to the outcomes achieved by individual therapists. This would emphasise that even within the 
realm of evidence-based practice, the role of the therapist is still important and would signal to 
patients that developing and maintaining effective relationships with therapists are paramount.  
Recommendations for future therapist effects research  
More therapist effect studies and more homogeneous studies are required to produce an overall 
robust therapist effect. Future research should aim to acquire and analyse the largest samples of 
practice-based data, in terms of both patients and therapists but particularly therapists, in order to 
use MLM and produce reliable estimates of effects. One of the largest standardized datasets of 
routinely collected data from services is that derived from the UK's IAPT initiative and yet while it 
gathers data on patients and clinical services, it fails to collect or be able to analyse data in relation 
to therapists and their contribution to patient outcomes. Datasets that are of a greater duration can 
allow the variability of therapist effects over time to be studied. Studies of therapist effects should 
use validated and meaningful outcome measures and should also report the manner of patient 
Therapist effects since Baldwin & Imel’s (2013) review   25 
allocation and measurement time-points more explicitly. Case-mix and other variables and the levels 
included in the multilevel analysis should also be reported. But perhaps most crucially, as noted 
earlier and in order to move towards studies designed as therapist effect studies, more information 
needs to be collected on a range of therapist variables together with data on personal qualities in 
addition to more standard information (e.g., number of years' experience, etc.). Very large samples 
from multiple sites would allow for the study of therapist effects in relation to clinic effects. Also, the 
role of the clinical supervisor. Hence, there is the potential for four-level models in which patients 
are nested within therapists, who are nested within clinical supervisors, who are nested within 
clinics.  
Conclusions  
Overall, this review has found that across a wide variety of contexts, treatments, outcome measures 
and patient groups, therapist effects are a significant and robust phenomenon. The average 
therapist effect found (5%) was within the 3–7% indicated by the previous systematic review 
(Baldwin & Imel 2013), thereby implying some stability to the therapist effects phenomenon. 
However, overall there was a large degree of heterogeneity across studies. Although studies are 
addressing new aspects (e.g., investigating therapist effects over time, low intensity treatments, and 
comparing outcome measures), reports with sufficient power at both patient and, in particular, 
therapist levels are clearly still required. The study of therapist effects can be considered a method 
to better understand therapist variability and, by doing so, to generate research questions with the 
aim of improving the effectiveness of the ‘average’ therapist as well as reducing the variability 
between therapists.  
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Figure 2. Funnel plot of ICCs for all models. Note:  Orange line indicates overall weighted mean by number of patients per therapist; each dot represents a model from a review study; 
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Note. ASI-Lite = Addiction Severity Index-Lite; BAI = Beck Anxiety Inventory; BDI = Beck Depression Inventory; BHM-20 = Behavioral Health Measure-20; BSI = Brief System Inventory; CCAPS-62 
= Counseling Center Assessment of Psychological Symptoms-62; CIS = Checklist Individual Strength; CORE-OM = Clinical Outcomes in Routine Evaluation-Outcome Measure; DDD = drinks per 
drinking day; GAD-7 = Generalised Anxiety Disorder-7; HAq-II = Revised Helping Alliance Questionnaire; IAPT = Improving Access to Psychological Therapies; IMD = Index of Multiple Depravation; 
MHI = Mental Health Index; OQ-45 = Outcome Questionnaire-45; PCL = PTSD Checklist; PDA = per cent days abstinent; PHQ-9 = Patient Health Questionnaire-9; PTSD = Post-traumatic stress 
disorder; PDS = Posttraumatic Diagnostic Scale; RCT = Randomised Control Trial; SF-36 = Short Form Health Survey; TOP = Treatment Outcome Package; URICA = University of Rhode Island Change 
Assessment; WSAS = Work and Social Adjustment Scale; 1published online in 2016 and thus included in review period; 2 The term ‘service’ is used in the UK and approximates the US term clinic or 
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Reported ICC values for RCT studies  




Mean overall ICC 
based on ICC 
values in column 3 
        
Erickson et al. (2012) 
Substance use – all .270 n/g 91 10 - .280 
Substance use – MET condition .290 n/g 91 10       -  
        
Goldsmith et al. (2015) 
Chalder fatigue – PR .100 n/g               296            3 .100 .065 
Chalder fatigue – SL .100 n/g 296 3   
SF-36 – PR .050 n/g 296 3        .025  
SF-36 – SL .010 n/g 296 3   
        
Moyers et al. (2016) Drinking outcomes – untransformed .214 .108-.338 700 38 
- 
.164 
Drinking outcomes – log transformed .114 .029-.221 700 38         -  
        
        
        
Mean ICC, weighted for no. of patients     
 
.129 
Mean ICC, weighted for no. of therapists 
    
 
.174 
Mean ICC, weighted for no. of patients per therapist 




Note. CI = confidence interval; ICC = Intraclass correlation co-efficient; MET = motivational enhancement therapy; n/g = not given; PR = Pragmatic Rehabilitation; RCT = 




Reported ICC values for practice-based studies  








Mean overall ICC 
based on ICC values in 
column 3 
        
University counseling        
        
Goldberg, Hoyt et al. 
(2016) OQ-45 - no predictors* .009 n/g 5794 158 
- 
.009 
 OQ-45 - controlled for case mix (average)* .009 n/g 5794 158 -  
        
Goldberg, Rousmaniere 
et al. (2016) OQ-45 – time as predictor* .010 n/g 6591 170 
- 
.011 
 OQ-45 – cases as predictor* .011 n/g 6591 170 -  
        
Hayes et al. (2015) OQ-45 – race fixed* .087 n/g 228 36 
- 
.139 
 OQ-45 – race varied* .191 n/g 228 36 -  
        
Hayes et al. (2016) CCAPS-62 (DI)* .039 n/g 3825 251 - .036 
 
CCAPS-62 (DI) – controlled for pre-
treatment score* .032 n/g 3825 251 
- 
 
        
Owen et al. (2016) BHM-20 – wellbeing* .004 n/g 13664 586 .004 .042 
 BHM-20 - symptom distress* .046 n/g 13664 586 .046  
 BHM-20 - life functioning* .075 n/g 13664 586 .075  
        
Primary care        
        
Ali et al. (2014) PHQ-9 .010 .003-.0038 1359 38 .010 .007 
 GAD-7 .009 .002-.0039 1366 38 .009  
 PHQ-9 controlled for age & gender .004 .000-.0043 1174 37 -  
 GAD-7 controlled for age & gender .006 .001-.0035 1190 37 -  
 
PHQ-9 controlled for visit number & 




GAD-7 controlled for visit number & 
duration .008 .001-.0043 1127 37 
- 
 
 PHQ-9 full sample .005 .001-.0024 2190 38 .005  
 GAD-7 full sample .002 .000-.0054 2197 38 .002  
 PHQ-9 above baseline .012 .002-.0060 703 37 -  
 GAD-7 above baseline .011 .002-.0057 811 37 -  
 
 
Table 4 (continued) 








Mean overall ICC 
based on ICC 
values in column 3 
Firth et al. (2015) 
PHQ-9 .028 n/g 6111 56 .028 .046 
GAD-7 .019 n/g 6111 56 .019  
WSAS .034 n/g 6111 56 .034  
PHQ-9 – controlled for case mix .064 n/g 6111 56 -  
GAD-7 – controlled for case mix .061 n/g 6111 56 -  
WSAS – controlled for case mix .070 n/g 6111 56 -  
        
Green et al. (2014) PHQ-9 .097 .058-.174 1122 21 
.097 
.098 
GAD-7 .098 .058-.176 1122 21 .098  
        
Pereira et al. (2017) 
PHQ-9 – controlled for pre-treatment score .073 n/g 4980 37 - .070 
PHQ-9 – controlled for pre- treatment score 
& case mix .067 n/g 4980 37   
        
Saxon & Barkham 
(2012) 
CORE-OM – without risk .078 n/g 10786 119 - .072 
CORE-OM – controlled for risk .066 n/g 10786 119 -  
        
Saxon et al. (2017) PHQ-9 .058 n/g 4034 61 - .058 
        
Mixed settings        
        
Chow et al. (2015) CORE-10 full sample .054 n/g 4580 69 - .052 
CORE-10 controlled for severity .051 n/g 4580 69 -  
        
Kraus et al. (2016) TOP – risk adjusted .129 n/g 3540 59 - .129 
        
Nissen-Lie et al. (2016) 
OQ-45 – total* .019 n/g 5828 158 .019 .060 
OQ-45 – symptom distress* .020 n/g 5828 158 .020  
OQ-45 – interpersonal relationships* .013 n/g 5828 158 .013 [.018 OQ-45] 
OQ-45 – social relationships* .019 n/g 5828 158 .019  
CORE-OM – wellbeing .100 n/g 520 31 .100  
CORE-OM – problems .100 n/g 520 31 .100  
CORE-OM – close relationships .200 n/g 520 31 .200 [.108 CORE-OM] 
CORE-OM – general .020 n/g 520 31 .020  





Table 4 (continued) 








Mean overall ICC 
based on ICC 
values in column 3 
        
Schiefele et al. (2017) 
BSI .055 n/g 668 97  .057 
BSI .090 n/g 636 120 [.067 BSI]  
BSI .055 n/g 752 71   
BHM-20 .038 n/g 11356 401 .038  
MHI .047 n/g 1194 60 .047  
OQ-45 .043 n/g 2561 143 .043  
CORE-OM .102 n/g 25842 789 .102  
PHQ-9 .027 n/g 5639 119 .027  
        
Specialist/focused 
settings      
 
 
Laska et al. (2013) 
PCL – controlled for pre-treatment score 
.117 n/g 192 25 - .108 
PCL – controlled for pre-treatment score – 
with rating score .099 n/g 192 25 -  
        
Wiborg et al. (2012)    CIS – fatigue severity .210 n/g 103 10 - .210 
        
Mean ICC, weighted for no. of patients      .047 
Mean ICC, weighted for no. of therapists      .048 
Mean ICC, weighted for no. of patients per therapist      .050 
        
 
 
Note. BHM-20 = Behavioral Health Measure -20; BSI = Brief Symptom Inventory; CCAPS-62 = Counselling Centre  Assessment of Psychological Symptoms; CI = confidence 
interval; CIS = Checklist Individual Strength; CORE-OM=Clinical Outcomes in Routine Evaluation-Outcome Measure; CORE-10= Clinical Outcomes in Routine Evaluation-10; 
DI = Distress Index; GAD-7 = Generalised Anxiety Disorder-7; IAPT = Improving Access to Psychological Therapies; ICC = Intraclass correlation co-efficient; n/g = not given; 
MHI = Mental Health Index; OQ-45 = Outcome Questionnaire-45; PCL = PTSD Checklist; PHQ-9 = Patient Health Questionnaire-9; RCT = Randomized Controlled Trial; 















2. Are the main outcomes to be measured clearly described in the Introduction or Methods 
section? 
 






3. Are the characteristics of the patients included in the study clearly described? 
 
In cohort studies and trials, inclusion and/or exclusion criteria should be given. In 





4. Are the interventions of interest clearly described? 
 






5. Are the distributions of principal confounders in each group of subjects to be compared clearly 
described? 
 
A list of principal confounders is provided. 
 
Yes 2 
Partially  1 
No  0 
 
6. Are the main findings of the study clearly described? 
 
Simple outcome data should be reported for all major therapist effects so that the reader can check the 
major analyses and conclusions. 









In non-normally distributed data the inter-quartile range of results should be reported. In normally 
distributed data the standard error, standard deviation or confidence intervals should be reported around the 
therapist effect. If the distribution of the data is not described, it must be assumed that the estimates used 





8. Have all important adverse events that may be a consequence of the intervention been reported? 
 
This should be answered yes if the study demonstrates that there was a comprehensive 





9. Have the characteristics of patients lost to follow-up been described? 
 
This should be answered yes where there were no losses to follow-up or where losses 
to follow-up were so small that findings would be unaffected by their inclusion. This 






10. Have actual probability values been reported (e.g. 0.035 rather than <0.05) for the main 






All the following criteria attempt to address the representativeness of the findings of the study 
and whether they may be generalised to the population from which the study subjects were 
derived. 
 
11. Were the subjects asked to participate in the study representative of the entire population 
from which they were recruited? 
 
The study must identify the source population for patients and describe how the 
patients were selected. Patients would be representative if they comprised the entire 
source population, an unselected sample of consecutive patients, or a random sample. 
Random sampling is only feasible where a list of all members of the relevant population exists. Where a 
study does not report the proportion of the source population from which the patients are derived, the 




Unable to determine 0 
 
12. Were those subjects who were prepared to participate representative of the entire population 
from which they were recruited? 
 
The proportion of those asked who agreed should be stated. Validation that the 
sample was representative would include demonstrating that the distribution of the 








13. Were the staff, places, and facilities where the patients were treated, representative of the 
treatment the majority of patients receive? 
 
For the question to be answered yes the study should demonstrate that the intervention 
was representative of that in use in the source population. The question 
should be answered no if, for example, the intervention was undertaken in a specialist 




Unable to determine 0 
 
Internal validity – bias 
 
14. Was an attempt made to blind study subjects to the intervention they have received? 
 
For studies where the patients would have no way of knowing which intervention they received, this 




Unable to determine 0 
 




Unable to determine 0 
 
16. If any of the results of the study were based on “data dredging”, was this made clear? 
 
Any analyses that had not been planned at the outset of the study should be clearly 





Unable to determine 0 
 
17. In trials and cohort studies, do the analyses adjust for different lengths of follow-up of 
patients, or in case-control studies, is the time period between the intervention and outcome 
the same for cases and controls? 
 
Where follow-up was the same for all study patients the answer should yes. If different 
lengths of follow-up were adjusted for by, for example, survival analysis the answer 





Unable to determine 0 
 
18. Were the statistical tests used to assess the therapist effects appropriate? 
 
Were the data analysed within a hierarchical structure (e.g. using Multilevel Modelling), using random 








19. Was compliance with the intervention/s assessed? 
 
Where there was non compliance with the allocated treatment or where there was 
contamination of one group, the question should be answered no. For studies where 
the effect of any misclassification was likely to bias any association to the null, the 




Unable to determine 0 
 
20. Were the main outcome measures used accurate (valid and reliable)? 
 
For studies where the outcome measures are clearly described, the question should 
be answered yes. For studies which refer to other work or that demonstrates the 




Unable to determine 0 
 
Internal validity - confounding (selection bias) 
 
21. Were the patients in different intervention groups (trials and cohort studies) or were the 
cases and controls (case-control studies) recruited from the same population? 
 
For example, patients for all comparison groups should be selected from the same 
hospital. The question should be answered unable to determine for cohort and casecontrol 
studies where there is no information concerning the source of patients 




Unable to determine 0 
 
22. Were study subjects in different intervention groups (trials and cohort studies) or were the 
cases and controls (case-control studies) recruited over the same period of time? 
 
For a study which does not specify the time period over which patients were recruited, 




Unable to determine 0 
 
23. Were study subjects randomised to intervention groups? 
 
Studies which state that subjects were randomised should be answered yes except 
where method of randomisation would not ensure random allocation. For example 




Unable to determine 0 
 
24. Was the randomised intervention assignment concealed from both patients and health care 
staff until recruitment was complete and irrevocable? 
 
All non-randomised studies should be answered no. If assignment was concealed 
 
 




Unable to determine 0 
 
25. Was there adequate adjustment for confounding in the analyses from which the main findings 
were drawn? 
 
This question should be answered no for trials if: the main conclusions of the study 
were based on analyses of treatment rather than intention to treat; the distribution of 
known confounders in the different treatment groups was not described; or the distribution 
of known confounders differed between the treatment groups but was not 
taken into account in the analyses. In nonrandomised studies if the effect of the main 
confounders was not investigated or confounding was demonstrated but no adjustment 




Unable to determine 0 
 
26. Were losses of patients to follow-up taken into account? 
 
If the numbers of patients lost to follow-up are not reported, the question should be 
answered as unable to determine. If the proportion lost to follow-up was too small 








27. Did the study have sufficient power to detect a therapist effect where the probability value for a difference 
being due to chance is less than 5%? 
 
How many therapists were there and how many patients did they treat? 
 
Were there at least 10 therapists in total? Ideally the number of therapists should be maximised, with a 
minimum of 100 recommended, and at least 50 required for statistical significance. Did all therapists treat 
at least 10 patients?   
 
 
³100 therapists all treating ³10 patients each 
5 
³100 therapists with some or all treating treating <10 patients, or 50-99 therapists all 
treating ³10 patients each  
4 
50-99 therapists with some or all therapists treating <10 patients 
3 
10-49 therapists all treating ³10 patients 
2 







Changes to original Downs & Black (1998) checklist: 
 
• 6. Are the main findings of the study clearly described? 
 
Changed from: 
Simple outcome data (including denominators and numerators) should be reported for all major findings so 
that the reader can check the major analyses and conclusions. 





 Changed to: 
Simple outcome data should be reported for all major therapist effects so that the reader can check the 
major analyses and conclusions. 






• 7. Does the study provide estimates of the random variability in the data for the main outcomes? 
 
Changed from: 
In non normally distributed data the inter-quartile range of results should be 
reported. In normally distributed data the standard error, standard deviation or confidence 
intervals should be reported. If the distribution of the data is not described, it 
must be assumed that the estimates used were appropriate and the question should 






In non-normally distributed data the inter-quartile range of results should be 
reported. In normally distributed data the standard error, standard deviation or confidence 
intervals should be reported around the therapist effect. If the distribution of the data is not described, it 






• 18. Were the statistical tests used to assess the main outcomes appropriate? 
 
Changed from: 
The statistical techniques used must be appropriate to the data. For example nonparametric 
methods should be used for small sample sizes. Where little statistical 
analysis has been undertaken but where there is no evidence of bias, the question 
should be answered yes. If the distribution of the data (normal or not) is not described 
it must be assumed that the estimates used were appropriate and the question should 




Unable to determine 0 
 
Changed to (based on Baldwin & Imel, 2013): 
 




Were the data analysed within a hierarchical structure (e.g. using Multilevel Modelling), using random 




Unable to determine 0 
 
• 19. Was compliance with the intervention/s reliable? 
 
Changed from: 
Where there was non compliance with the allocated treatment or where there was 
contamination of one group, the question should be answered no. For studies where 
the effect of any misclassification was likely to bias any association to the null, the 








 19. Was compliance with the intervention/s assessed? 
 
Where there was non-compliance with the allocated treatment or where there was 
contamination of one group, the question should be answered no. For studies where 
the effect of any misclassification was likely to bias any association to the null, the 




Unable to determine 0 
 
• 27. Did the study have sufficient power to detect a clinically important effect where the probability value 
for a difference being due to chance is less than 5%? 
 
Changed from: 
Sample sizes have been calculated to detect a difference of x% and y%. 
 
Changed to (based on Adelson & Owen, 2012; Baldwin & Imel, 2013; Hox, 2010 & Schiefele et al., 
2017): 
 
27. Did the study have sufficient power to detect a therapist effect where the probability value for a 
difference being due to chance is less than 5%? 
 
How many therapists were there and how many patients did they treat? 
 
Were there at least 10 therapists in total? Ideally the number of therapists should be maximised, with a 
minimum of 100 recommended, and at least 50 required for statistical significance. Did all therapists treat 
at least 10 patients?   
 
³100 therapists all treating ³10 patients each 5 
³100 therapists with some or all treating treating <10 patients, or 50-99 therapists all 
treating ³10 patients each  
4 
50-99 therapists with some or all therapists treating <10 patients 
3 
10-49 therapists all treating ³10 patients 
2 






Appendix B - Quality Checklist Results 
 
Quality checklist results from main rater 
  Question number 
Type of 
study 
Author(s) and date 






















































































































































































































































Ali et al. (2014) 
 
1 1 1 1 2 1 1 0 1 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 1 1 3 26 
Chow et al. (2015) 1 1 1 0 2 1 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 1 N/A N/A 1 1 4 24 
 


























































Table B1 continued                 
  Question number  
Type of 
study 
Author(s) and date 






































































































































































































































































































































































Nissen-Lie et al.  
(2016) 
1 1 1 0 1 1 1 0 1 0 1 1 1 0 0 1 1 1 1 1 1 1 N/A N/A 1 1 5 25 
 




























































Table B1 continued                      
  Question number  
Type of 
study 
Author(s) and Date 




















































































































































































































































Wiborg et al. (2012) 
 
1 1 1 1 2 1 1 0 1 0 1 1 1 0 0 1 1 1 1 1 1 1 N/A N/A 1 1 1 22 









Quality checklist ratings – independent raters 
 Question number 
Author(s) and Date 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Total 
Rater 1                             
  Erickson et al. (2012) 1 1 1 1 1 1 1 0 1 1 0 0 1 0 0 0 1 1 1 1 1 1 1 0 1 0 1 19 
  Pereira et al. (2017) 1 1 1 1 2 1 1 0 1 1 1 1 0 0 0 1 1 1 1 1 0 1 0 0 0 0 2 20 
  Saxon & Barkham (2012) 1 1 1 0 2 1 1 0 1 0 1 1 1 0 0 1 1 1 1 1 0 1 0 0 0 0 5 22 
  Wiborg et al. (2012) 1 1 1 1 2 1 1 0 1 0 1 1 1 0 0 1 1 1 1 1 0 1 0 0 1 0 1 20 
Rater 2                             
  Saxon et al. (2017) 1 1 1 1 1 1 1 0 1 1 1 1 1 0 0 1 1 1 0 1 1 1 0 0 1 1 4 24 
  Hayes et al. (2015) 1 1 1 0 1 0 1 0 1 1 1 1 1 0 0 1 1 1 0 1 1 1 0 0 1 1 1 19 
  Goldsmith et al. (2015) 1 1 1 1 0 1 1 0 0 1 1 1 1 0 0 1 1 1 0 0 0 0 1 0 0 0 0 14 
  Laska et al. (2013) 1 1 1 1 1 1 1 0 1 1 1 1 1 0 0 1 1 1 0 1 1 1 0 0 1 1 1 21 
Note. Both independent raters showed substantial agreement with the original rater using Cohen’s kappa (κ) for inter-rater reliability. For rater 1, κ=0.72 and rater 2, κ=0.66 (both 
p<0.01).   
 
